The Health Sciences Institute is intended to provide cutting-edge health information.
Nothing on this site should be interpreted as personal medical advice. Always consult with your doctor before changing anything related to your healthcare.

Yet another way this serial killer claims its victims

Aspirin is a miracle drug, all right. It’s a miracle that it hasn’t been moved behind the pharmacy counter by now!

For something so benign-looking, cheap, and easy to buy, it’s shocking at how deadly it can be. And that’s even at a “baby” dose of 81 mg.

As many have learned the hard way, it’s an extremely risky med — even when it tastes like oranges or cherries!

And along with the very real threat of internal bleeding (among other catastrophic side effects), we can now add something else to this “wonder” drug’s rap sheet: a doubling of the likelihood of a man developing the most dangerous skin cancer of all, melanoma.

So, if you’re taking a daily aspirin because you think it will prevent a stroke or heart attack or even offer some kind of protection against colon cancer, prepare to trade your skin – and maybe even your life – for those promises, which will more than likely turn out to be empty.

The devil is in the details

For decades, we were told that the simplest way to avert a heart attack is to simply pop a low-dose aspirin daily. But not even the FDA buys that story anymore.

Four years ago, the agency “carefully” examined the “scientific data” and realized that while researchers had found no real evidence that aspirin will prevent a heart attack, they did find some really hazardous side effects, including “dangerous bleeding into the brain or stomach.”

Well, that sure took long enough for the FDA to figure out. I mean, aspirin has only been around for over a century!

But its deadly side effects don’t stop there – and the latest study shows how this common painkiller can actually kill you by sacking you with the deadliest form of skin cancer.

In this new study, researchers at Chicago’s Feinberg School of Medicine followed close to 3,000 total patients of both sexes and ranging in age from 18 to 89. Within that group, nearly 1,200 had been taking a daily aspirin for a year or more.

After tracking their health status for five years, the researchers found that compared to those who didn’t take the drug, the men who popped a daily aspirin doubled their risk of being diagnosed with melanoma.

And even at the low dose of 81 mg, that danger remained.

Now, interestingly, the Feinberg scientists didn’t find this increased melanoma threat to be true for women. Lead researcher Dr. Beatrice Nardone said that could be for many reasons, one being that women may have more “protective enzymes” than men that can help to prevent skin cancer.

One of those watchdog enzymes is called superoxide dismutase, or SOD, an extremely important natural antioxidant that can counteract the damage done by oxidative stress. Having lower levels of SOD can result in unchecked “oxidative cellular damage in men,” said Dr. Nardone.

Of course, that doesn’t mean that aspirin is somehow safer (or safe at all) for women to take, as it’s also possible that further research will connect aspirin and melanoma to the fairer sex as well.

And if you’ve been sold on an aspirin regime based on news stories about how this “miracle” medicine can prevent cancer, especially colon cancer, know that there’s a lot more to the story than simply headlines like “Aspirin prevents cancer.”

The study at the root of a lot of that aspirin-taking hysteria came from a group called the U.S. Preventive Services Task Force (USPSTF), a panel of experts that dispenses advice to docs all over the U.S.

While headlines ran nonstop several years ago about how an aspirin a day could keep you safe from colon cancer, as they say, the devil is in the details.

And the details in that research were that the people who appeared to have lower rates of colon cancer were taking gigantic doses — up to 1,200 mg — of aspirin daily for decades. Yikes!

Swallowing that much – the equivalent of nearly 15 low-dose aspirin pills a day for years on end — would send your chances of suffering a GI bleed off the charts! And just last year, I told you how researchers out of the University of California at Irvine found that aspirin can actually supercharge colon cancer cells, making them even more deadly.

So, when you see a bottle of aspirin, recognize it for what it really is: a dangerous drug that you should only be reaching for if you think you’re having a heart attack, not to prevent one.

And if you really want to make sure the odds are in your favor for dodging cancer, don’t even touch one aspirin pill!

“Daily aspirin linked to double melanoma risk in men” Northwestern University, May 3, 2018, ScienceDaily, sciencedaily.com

Get a free copy of 5 Household Items that Cause Cancer

By texting HSI to 844-539-1128, you are providing your electronic signature expressly consenting to be called and texted (including by prerecorded messages, using an autodialer, and/or automated means) with alerts, stories, reports, and marketing communications from Institute of Health Sciences, LLC. and its authorized representatives at the phone number you provide, including landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also consent and unconditionally agree to our Privacy Policy and Terms of Use, including the arbitration provision and class action waiver contained therein. Msg&data rates may apply. 15 Msgs/Month. You are not required to agree to this as a condition of making a purchase.

Terms & Conditions

The following Terms and Conditions apply to your use of the website located at hsionline.com (the “website”) and any text messages that you send to or receive from the Institute of Health Sciences, L.L.C. These Terms and Conditions constitute a binding agreement (“Agreement”) between you (“you”) Institute of Health Sciences, L.L.C (“we”, “us”, etc.)  Please read these terms carefully. 

By providing your telephone number to us, texting us a short code listed on the website, or otherwise indicate your agreement to these Terms and Conditions, you are agreeing to the mandatory arbitration provision and class action waiver below. 

ARBITRATION IS MANDATORY AND THE EXCLUSIVE REMEDY FOR ANY AND ALL DISPUTES RELATED TO THIS WEBSITE, THIS AGREEMENT, AND ANY TELEPHONE CALLS, EMAILS, OR TEXT MESSAGES THAT YOU RECEIVE FROM OR ON BEHALF OF US, UNLESS SPECIFIED BELOW OR UNLESS YOU OPT-OUT.

Text Messaging and Telemarketing Terms and Conditions

When you provide your telephone number on this website or send a text message to us with or from a short-code, you agree to receive alerts and communications, and marketing messages including those sent via automated telephone dialing system, text messages, SMS, MMS, and picture messages from Institute of Health Sciences, L.L.C at the phone number you provide on this website or the phone number from which you text the short code, including on landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also agree to the mandatory arbitration provision and class action waiver below. Your consent is not required to purchase goods or services. Message & data rates may apply.

You may opt-out at any time by texting the word STOP to the telephone number from which you receive the text messages.  Call 1-888-213-0764 to learn more.  By providing your telephone number, you agree to notify us of any changes to your telephone number and update your account us to reflect this change. Your carrier may charge you for text messages and telephone calls that you receive, or may prohibit or restrict certain mobile features, and certain mobile features may be incompatible with your carrier or mobile device. Contact your carrier with questions regarding these issues.

Dispute Resolution by Binding Arbitration and Class Action Waiver

Any dispute relating in any way to telephone calls, emails, or text messages that you receive from or on behalf of Institute of Health Sciences, L.L.C this website, or this Agreement (collectively “Disputes”) shall be submitted to confidential arbitration and shall be governed exclusively by the laws of the State of Maryland, excluding its conflict of law provisions.  For the avoidance of doubt, all claims arising under the Telephone Consumer Protection Act and state telemarketing laws shall be considered “Disputes” that are subject to resolution by binding individual, confidential arbitration.

If a Dispute arises under this Agreement, you agree to first contact us at 1-888-213-0764 or help@hsionline.com. Before formally submitting a Dispute to arbitration, you and we may choose to informally resolve the Dispute.  If any Dispute cannot be resolved informally, you agree that any and all Disputes, including the validity of this arbitration clause and class action waiver, shall be submitted to final and binding arbitration before a single arbitrator of the American Arbitration Association (“AAA”) in a location convenient to you or telephonically. Either you or we may commence the arbitration process by submitting a written demand for arbitration with the AAA, and providing a copy to the other party.  The arbitration will be conducted in accordance with the provisions of the AAA’s Commercial Dispute Resolutions Procedures, Supplementary Procedures for Consumer-Related Disputes, in effect at the time of submission of the demand for arbitration.  Except as may be required by law as determined by the arbitrator, no party or arbitrator may disclose the existence, content or results of any arbitration hereunder without the prior written consent of both parties. Institute of Health Sciences, L.L.C will pay all of the filing costs.  Without limiting the foregoing, YOU EXPRESSLY AGREE TO SUBMIT TO ARBITRATION ALL DISPUTES RELATING TO ANY TEXT MESSAGES OR TELEPHONE CALLS YOU RECEIVE FROM OR ON BEHALF OF US OR ANY ENTITY WITH WHOM WE MAY SHARE YOUR TELEPHONE NUMBER.  Further, we both agree that all entities with whom we share your telephone numbers shall be third party beneficiaries of this Agreement to Arbitrate Disputes, and that those entities have the same rights as Institute of Health Sciences, L.L.C to enforce this arbitration provision.

Notwithstanding the foregoing, the following shall not be subject to arbitration and may be adjudicated only in the state and federal courts of Maryland: (i) any dispute, controversy, or claim relating to or contesting the validity of our or one of our family company’s intellectual property rights and proprietary rights, including without limitation, patents, trademarks, service marks, copyrights, or trade secrets; (ii) an action by us for temporary or preliminary injunctive relief, whether prohibitive or mandatory, or other provisional relief; (iii) any legal action by us against a non-consumer; or (iv) interactions with governmental and regulatory authorities.  You expressly agree to refrain from bringing or joining any claims in any representative or class-wide capacity, including but not limited to bringing or joining any claims in any class action or any class-wide arbitration.

The arbitrator’s award shall be binding and may be entered as a judgment in any court of competent jurisdiction. To the fullest extent permitted by applicable law, no arbitration under this Agreement may be joined to an arbitration involving any other party subject to this Agreement, whether through a class action, private attorney general proceeding, class arbitration proceedings or otherwise.

YOU UNDERSTAND THAT YOU WOULD HAVE HAD A RIGHT TO LITIGATE IN A COURT, TO HAVE A JUDGE OR JURY DECIDE YOUR CASE AND TO BE PARTY TO A CLASS OR REPRESENTATIVE ACTION.  HOWEVER, YOU UNDERSTAND AND AGREE TO HAVE ANY CLAIMS DECIDED INDIVIDUALLY AND ONLY THROUGH ARBITRATION.  You shall have thirty (30) days from the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, to opt out of this arbitration agreement, by contacting us by email at help@hsionline.com or by mail Health Sciences Institute, PO Box 913, Frederick, MD 21705-0913. If you do not opt out by the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, then you are not eligible to opt out of this arbitration agreement.

Electronic Signatures

All information communicated on the website is considered an electronic communication.  When you communicate with us through or on the website, by text message or telephone, or via other forms of electronic media, such as e-mail, you are communicating with us electronically.  You agree that we may communicate electronically with you and that such communications, as well as notices, disclosures, agreements, and other communications that we provide to you electronically, are equivalent to communications in writing and shall have the same force and effect as if they were in writing and signed by the party sending the communication.

You further acknowledge and agree that by clicking on a button labeled “ORDER NOW”, “SUBMIT”, “I ACCEPT”, “I AGREE”, “YES”, by texting a short code to us in response to a request on this website, or by clicking or similar links or buttons, you are submitting a legally binding electronic signature and are entering into a legally binding contract.  You acknowledge that your electronic submissions constitute your agreement and intent to be bound by this Agreement.  Pursuant to any applicable statutes, regulations, rules, ordinances or other laws, including without limitation the United States Electronic Signatures in Global and National Commerce Act, P.L. 106-229 (the “E-Sign Act”) or other similar statutes, YOU HEREBY AGREE TO THE USE OF ELECTRONIC SIGNATURES, CONTRACTS, ORDERS AND OTHER RECORDS AND TO ELECTRONIC DELIVERY OF NOTICES, POLICIES AND RECORDS OF TRANSACTIONS INITIATED OR COMPLETED THROUGH THE WEBSITE.  Furthermore, you hereby waive any rights or requirements under any statutes, regulations, rules, ordinances or other laws in any jurisdiction which require an original signature, delivery or retention of non-electronic records, or to payments or the granting of credits by other than electronic means You may receive a physical paper copy of this contract by contacting us at help@hsionline.com.

Privacy Policy

Please read our Privacy Policy, which is incorporated herein by reference.  In the event of any conflict between these Terms and Conditions and the Privacy Policy, these Terms shall control.

Contact Us

You may contact us by telephone at 1-888-213-0764 or by email at help@hsionline.com.